@misc{Trębacz_Oksana_The_2016,
 author={Trębacz, Oksana},
 address={Kraków},
 howpublished={online},
 year={2016},
 school={Wydział Lekarski},
 language={pol},
 abstract={Introductio nUse of contrast media in heart failure (HF) patients can cause a contrast-induced nephropathy (CIN), which can be prevented by a continuous veno-venous hemofiltration (CVVH). Aims To assess safety of CVVH, its influence on heart- and renal failure markers, risk of CIN and prognosis. Methods Half of 52 HF and renal failure patients undergoing coronary angiography/PCI were treated by CVVH (group A), while others were treated in a standard manner. Results In group A creatinine level decreased significantly at day 1 post PCI (161,87±63,4 vs 124,71±39,8 μmol/l, p=0,003), while it raised in group B (129,9±38,1 vs 136,4±43,6, p=0,049). In group A, NT-proBNP level dropped significantly but CRP level raised. CIN frequency in group A was non-significantly lower (15,4%, vs 26,9%, p=0,49). Female gender was an independent predictor of CIN (OR 2,15, CI (1,03-4,49), p=0,04). Puncture site bleedingincidence was higher in CVVH women. One-year survival was significantly higher in group A (p=0,03). Conclusions CVVH in HF patients decreases creatinine and NT-proBNP levels and non-significantly lowers CIN risk, probably providing 1-year survival benefit while increasing bleeding risk in women.},
 title={The use of continuous veno-venous hemofiltration in patients with an advanced heart failure and at high risk of contrast induced nephropathy who undergone interventional cardiac procedures},
 type={Praca doktorska},
 keywords={continuous veno-venous hemofiltration, contrast induced nephropathy, cardio-renal syndrome, heart failure},
}